Bolt Biotherapeutics Competitors and Similar CompaniesClear all
Bolt Biotherapeutics's competitors and similar companies include Forbius, NextCure and Immunicom.
 Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. |  Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. |  NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. |  Immunicom Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. | |
Founding Date | Founding Date 2015 | Founding Date 2011 | Founding Date 2015 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | ||||
Locations | Locations Redwood City, US HQ | Locations Austin, US HQ Montréal, CA | Locations Beltsville, US HQ | Locations San Diego, US HQ |
Employees | Employees 943% increase | Employees 9 | Employees N/A | Employees 25 |
Valuation ($) | Valuation ($) 25.6 m | Valuation ($) N/A | Valuation ($) 39.2 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($69.2m) (FY, 2023) | Net income N/A | Net income ($55.7m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 177.5m | Total funding raised N/A | Total funding raised $ 160m | Total funding raised $ 21.9m |
For sources of this data, please see the company profile
View Company Profiles
Forbius
HQ
Austin, US
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View companyNextCure
HQ
Beltsville, US
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View companyImmunicom
HQ
San Diego, US
Employees
25
Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates.
View company